EX-2.1
from 8-K
99 pages
Agreement and Plan of Merger Among Sorrento Therapeutics, Inc., as Parent Vh Merger Sub I, Inc., as Merger Sub Vh Merger Sub II, LLC, as Merger LLC Virex Health Inc. as the Company and Fortis Advisors LLC as the Stockholders’ Representative Dated as of January 14, 2022 1
12/34/56
EX-2.1
from 8-K
87 pages
Agreement and Plan of Merger by and Among: Sorrento Therapeutics, Inc., a Delaware Corporation; Sp Merger Sub, Inc., a Delaware Corporation; Smartpharm Therapeutics, Inc., a Delaware Corporation; and John C. Thomas, Jr., as the Stockholders’ Representative Dated as of August 20, 2020
12/34/56
EX-2.1
from 8-K
106 pages
Agreement and Plan of Merger by and Among Scilex Holding Company, Sigma Merger Sub, Inc., Semnur Pharmaceuticals, Inc., Fortis Advisors LLC, Solely as the Equityholders’ Representative And, Solely With Respect to Section 1.8(a), Section 3.11 and Article X, Sorrento Therapeutics, Inc. Dated as of March 18, 2019
12/34/56
EX-2.1
from 8-K
104 pages
Share Purchase Agreement by and Among Tnk Therapeutics, Inc., Virttu Biologics Limited, the Shareholders of Virttu Biologics Limited, Dayspring Ventures Limited, as the Shareholders’ Representative And, Solely With Respect to Sections 1.2(a), 1.4(b), 1.6, 1.7, 6.6, 6.8, 7.4 and 8.5(a) and Articles V and X, Sorrento Therapeutics, Inc. Dated as of April 27 2017
12/34/56
EX-2.1
from 8-K
97 pages
Stock Purchase Agreement by and Among Sorrento Therapeutics, Inc., Scilex Pharmaceuticals Inc., the Stockholders of Scilex Pharmaceuticals Inc., and Spi Shareholders Representative, LLC, as the Stockholders’ Representative Dated as of November 8, 2016
12/34/56
EX-2.1
from 8-K
60 pages
Agreement of Merger by and Among: Sorrento Therapeutics, Inc., a Delaware Corporation; Catalyst Merger Sub, Inc., a Delaware Corporation; Concortis Biosystems, Corp., a Delaware Corporation; and Zhenwei Miao and Gang Chen Dated as of November 11, 2013
12/34/56
